Jonathan Jay Mazelsky - 09 Jan 2026 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role: Director
Signature: /s/ Jessica Nielsen Causey, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol: XRAY
Transactions as of: 09 Jan 2026
Net transactions value: +$1,878
Form type: 4
Filing time: 13 Jan 2026, 16:36:44 UTC
Previous filing: 02 Jan 2026
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
MAZELSKY JONATHAN JAY	Director	C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Jonathan Jay Mazelsky	13 Jan 2026	0001556270

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XRAY	Common Stock	Award	$0	+395	+1.4%	$0.000000	28,847	09 Jan 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XRAY	Phantom Stock (Directors' Deferred Compensation) DDC	Award	$1,878	+154	+1.1%	$12.22	14,535	09 Jan 2026	Common Stock	154		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2	Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.
F3	Comprised of phantom stock acquired as a result of accrued dividends.